Saint Lucia is positioning itself at the forefront of a healthcare revolution following the announcement of a strategic partnership between CariGenetics Saint Lucia and Laboratory Services & Consultations Ltd. This partnership promises to bring advanced genetic testing, genomics and precision medicine closer to patients across the island and the wider Eastern Caribbean.
The collaboration combines the laboratory infrastructure of Laboratory Services & Consultations Ltd. with the specialized genomics expertise of CariGenetics, creating a pathway for patients to access sophisticated diagnostic services locally rather than relying on overseas laboratories. Medical professionals involved in the initiative say the move is expected to reduce turnaround times for critical test results, lower costs and improve access to personalized treatment options.
A major focus of the partnership is the expansion of advanced cancer diagnostic services. Through local access to tumour genetic testing and immunohistochemistry, healthcare providers will be better equipped to understand the molecular characteristics of a patient’s cancer, allowing for more informed decisions on diagnosis, treatment plans and specialist referrals.
The development comes amid growing concern over the rising burden of cancer across the Caribbean and the need for stronger regional diagnostic capacity.
Speaking at the launch ceremony, Laboratory Director of Laboratory Services & Consultations Ltd., Dr. Stephen King, emphasized the significance of precision diagnostics in modern healthcare.
“It’s a network of professionals looking at the data, analysing and making sure that the correct information, reliable information is given to the clinician so that the right treatment can be affected. That is a quality assured process which laboratories must do,” Dr. King said.
The partnership will also broaden access to clinical genetic testing services aimed at shifting healthcare from a reactive model to one focused on prevention. Planned services include pharmacogenomics, which helps determine how an individual’s genetic profile affects their response to medications, and polygenic risk assessments that can identify inherited risks for common chronic diseases.
Chief Executive Officer of CariGenetics Saint Lucia, Devy Frederick, said the initiative goes beyond introducing new technology and focuses on ensuring meaningful integration into patient care.
“Looking ahead we want to support greater access to testing, we want to strengthen local capacity and we really want to work with clinicians on the appropriate use of these services,” Frederick said.
Founder of CariGenetics, Dr. Carika Weldon, highlighted the importance of building Caribbean-led genomic capacity, noting that Caribbean populations have historically been underrepresented in global genetic research. She said the partnership will help ensure that future medical insights and innovations are informed by data that reflects the unique genetic makeup of Caribbean people.
While the programme is being launched in Saint Lucia, stakeholders envision a broader regional framework that would serve the Organisation of Eastern Caribbean States (OECS). Such a model would promote shared expertise, harmonized standards and localized sample-processing capabilities throughout the region.
OECS Director General Dr. Didacus Jules described the initiative as more than a business arrangement, calling it a significant step toward regional scientific advancement.
He said the partnership demonstrates that the Eastern Caribbean possesses the ambition, talent and emerging infrastructure needed to play a meaningful role in the future of medicine.
Beyond patient care, the introduction of local genetic sequencing capacity is expected to create opportunities in public health, environmental science and research. The technology could strengthen disease surveillance, improve pathogen tracking, support monitoring of antimicrobial resistance and enhance pandemic preparedness efforts.
It may also assist scientists in building reference genomes for regional wildlife and monitoring ecosystems, while creating opportunities to develop and retain scientific talent within the Caribbean.
As the initiative moves forward, both organizations say they will continue working closely with local and regional stakeholders to ensure the services align with national health priorities and contribute to Saint Lucia’s emergence as a hub for Caribbean-led scientific innovation.
